Santhera Pharmaceuticals
Pratteln, Basel-Landschaft, Switzerland · Biopharma, Biotechnology, Health Care
Santhera Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of innovative medicines for the treatment of rare neuromuscular and pulmonary diseases.
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Pratteln, Basel-Landschaft, Switzerland
- Employees
- 78
- Industries
- Biopharma, Biotechnology, Health Care
- Status
- Private
- Website
- santhera.com
- Company page
Recent activity at Santhera Pharmaceuticals
- : Santhera Pharmaceuticals Appoints Marc Clausse as Chief Commercial Officer
- : Santhera Pharmaceuticals Forms Exclusive Agreement with Biomedica for AGAMREE® Distribution in Russia. (date Fundz recorded it)
- : Santhera Pharmaceuticals raises CHF 20 million in growth funding led by R-Bridge and Highbridge Capital Management to accelerate global AGAMREE rollout.
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
About Santhera Pharmaceuticals: questions and answers
What does Santhera Pharmaceuticals do?
Santhera Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of innovative medicines for the treatment of rare neuromuscular and pulmonary diseases.
Where is Santhera Pharmaceuticals headquartered?
Santhera Pharmaceuticals is headquartered in Pratteln, Basel-Landschaft, Switzerland.
How many employees does Santhera Pharmaceuticals have?
Santhera Pharmaceuticals has about 78 employees.
What is the latest news on Santhera Pharmaceuticals?
On Mar 10, 2026, Santhera Pharmaceuticals Appoints Marc Clausse as Chief Commercial Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy